MediWound (MDWD) Capital Expenditures Growth (3y) (2016 - 2025)
MediWound (MDWD) Capital Expenditures Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | 16.27% |
| 10 | MediWound | 166.67 Mn | 161.87 Mn | 278,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -96.62% |
| Mar 31, 2025 | -81.65% |
| Dec 31, 2024 | 258.73% |
| Jun 30, 2024 | -387.70% |
| Mar 31, 2024 | -79.41% |
| Dec 31, 2023 | 196.99% |
| Sep 30, 2023 | -92.56% |
| Jun 30, 2023 | -120.01% |
| Mar 31, 2023 | -118.64% |
| Jun 30, 2022 | 10.73% |
| Mar 31, 2022 | 12.52% |
| Dec 31, 2021 | 3.97% |
| Jun 30, 2021 | 49.09% |
| Mar 31, 2021 | -23.41% |
| Dec 31, 2020 | -34.76% |
| Sep 30, 2020 | 22.09% |
| Jun 30, 2020 | 16.05% |
| Mar 31, 2020 | 9.77% |
| Dec 31, 2019 | -124.70% |
| Sep 30, 2019 | 47.04% |